NPPA issued a notification regarding the fixation of the retail price of Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate (As Extended Release) 25 mg + Cilnidipine IP 10 mg+ Telmisartan IP 40 mg for M/s Pure and Cure Healthcare Pvt. Ltd (Manufacturer) & M/s Alkem Wellness Ltd (Marketer)

May 10, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on May 07, 2026, issued a notification regarding the fixation of the retail price of Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate (As Extended Release) 25 mg + Cilnidipine IP 10 mg+ Telmisartan IP 40 mg for M/s Pure and Cure Healthcare Pvt. Ltd (Manufacturer) & M/s Alkem Wellness Ltd (Marketer).

It states that the price for each hard gelatin capsule containing: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate (As Extended Release) 25 mg + Cilnidipine IP 10 mg+ Telmisartan IP 40 mg has been fixed at Rs. 11.83/- excluding GST.

[Notification no. - 19(5142)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT